
A laboratory device regrowed almost all the hairs of bald mice in a month, better than standard treatments for baldness like minoxidil or finasteride. The study, published in 2026 in the journal Nature Communications, targets theandrogenetic alopeciathe most common form of baldness that affects more than 1.5 billion people worldwide. Its particularity: taking the familiar appearance of an experimental electric comb, capable of delivering tiny pulses and therapeutic molecules to the heart of hair follicles.
Baptized Detanglethis bioelectronic comb was developed by a team from Beihang University in China to transform a daily gesture into a targeted treatment. “Current pharmacological treatments for androgenetic alopecia face difficulties due to systemic side effects of oral medications or limited effectiveness of topical applications. We are developing a comb-shaped bioelectronic system, named ‘Detangle’, for effective treatment of androgenetic alopecia during daily combing“, write the authors.
How the Detangle Electric Comb works on the hair follicle
To the naked eye, Detangle looks like a simple comb, but its teeth house electrodes of different heights and small drug reservoirs. When passing it over the skin, the teeth slightly lift the scalp and create a local electric field of approximately 260 volts per meter. “Detangle features electronic teeth incorporating electrodes of differentiated heights and drug loading modules, which generate an enhanced electric field penetrating up to approximately 9 times deeper into hair follicle regions than conventional external application“, describe the authors.
© Nature Communications
End of baldness? Discover Detangle, the bioelectronic comb that outperforms Finasteride.
This field makes cell membranes more permeable and pushes two genetic treatments into the follicles, located about 660 micrometers below the skin’s surface, or 0.66 millimeters. The researchers used a DNA plasmid encoding the VEGF-A protein, which stimulates blood vessels around the follicle, and an siRNA targeting the SRD5A2 gene to curb the production of dihydrotestosterone, the hormone that causes follicles to shrink in androgenetic alopecia. In mice made bald, brushed once every three days for 28 days, regrowth covered almost 100% of the treated areas, compared to around 70% with minoxidil, and the device also exceeded finasteride.
Detangle about current treatments for androgenetic alopecia
The success of the device is due to an old problem with traditional lotions: the skin barrier. “Safe and effective delivery remains key to therapeutic outcome in androgenetic alopecia“, recall the authors.
For human baldness, this is not a promise of cure but a preclinical proof of concept. The researchers point out that follicles, hormones and long-term safety will have to be studied in humans before hoping for a Detangle comb in the bathroom.